Increasing Consumer Adoption to Increase Demand for Pancreatic & Biliary Stents

Posted by Merin John on May 18th, 2021

Pancreatic and biliary stents have gained significant popularity over the years. Constant innovations and advancement in products, increased awareness about Pancreatic and Biliary Stents for various pancreatic disease applications, and the availability of funding & support from governments for the R&D of advanced Pancreatic and Biliary Stents are among the most important factors that are estimated to fuel the growth of the Pancreatic and Biliary Stents during the forecast period.

According to the latest research by PMR, the global pancreatic and biliary stents market is estimated to account for over US$ 460 Million in terms of value by the end of 2029. The pancreatic and biliary stents market report also projects a significant growth potential with an estimated average Y-o-Y growth rate of nearly 5% during the forecast period.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/28561

Company Profiles

Cook Medical Inc.

Boston Scientific Corporation

CONMED Corporation

Olympus Corporation

Medtronic Plc.

Taewoong Medical Co., Ltd.

ENDO-FLEX GmbH.

ELLA-CS, s.r.o

Becton, Dickinson and Company

Abbott Laboratories

Key Dynamics: Pancreatic and Biliary Stents Market

Plastic pancreatic and biliary stents, being lightweight and among the most economical in nature, are witnessing high adoption rates across hospitals and ambulatory surgical centers. Pancreatic and Biliary Stents are easy to implant and have a low rate of erosion in fully covered metallic stents.

Manufacturers are increasingly focusing on improving the levels of safety and efficacy offered by pancreatic and biliary stents, primarily to rate themselves higher on the excellence scale and garner better market shares. For this purpose, they are investing heavily on research and development.

The growing importance of better patient management as an attribute to measure the sense of wellbeing of a patient has a direct impact on the growth of healthcare sector. Moreover, the increasing requirement of intensive care in pancreatic cancer is boosting the number of orders for pancreatic and biliary stents.

The extended adoption of pancreatic and biliary stents for the prevention of pancreatic cancer at ambulatory care centers and hospitals under the guidance of licensed caregivers is also likely to boost the pancreatic and biliary stents market over the forecast period.

Reduction in the wastage of pancreatic and biliary secretion when used with properly tested pancreatic and biliary stents is boosting the popularity of the latter among oncologists, physicians, and surgeons. Plastic pancreatic and biliary stents also find wide acceptance among patients owing to a significant reduction in costs of the treatment of benign biliary strictures.

Like it? Share it!


Merin John

About the Author

Merin John
Joined: December 11th, 2020
Articles Posted: 262

More by this author